美克
chinese
隐藏导航
x
Search
logo

Medomics

Life saving diagnostic products and technologies

VIEW MORE
这是描述信息
美克

ABOUT US

Jiangsu Medomics Medical Technology Co.,Ltd

Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. 

  • 2017


    The company was established in

  • 16.5

    Million

    Registered capital

  • 40

    +Countries and regions

    Antibody detection kit has been exported

wealth
Medomics has launched Candida albicans/ Trichomonas vaginalis/ Gardnerella vaginalis antigen Combo Test Kit (LFIA)

Company Exhibition

Medomics has launched Candida albicans/ Trichomonas vaginalis/ Gardnerella vaginalis antigen Combo Test Kit (LFIA)

NEWS  INFORMATION

Medomics

Medomics has launched Candida albicans/ Trichomonas vaginalis/ Gardnerella vaginalis antigen Combo Test Kit (LFIA)

 Reproductive tract infection is an important part of systemic infection and has become a major public health problem in the world. Recent studies have shown that reproductive tract infection is closely related to tumor occurrence, infertility, ectopic pregnancy, premature rupture of membranes and premature delivery and so on. Almost all reproductive tract infections are accompanied by changes of genital tract microenvironment.   There are several common pathogens which are easy to cause gynecologic diseases in women:   1)Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial barriers and immune defenses. Their perturbation can lead to fungal outgrowth and the development of mucosal infections such as oropharyngeal or vulvovaginal candidiasis, and patients with compromised immunity are susceptible to life-threatening systemic infections.   2)Trichomonas vaginalis is a motile organism with a size comparable to a white blood cell. It has at least 4 flagella that provide undulating motility. The organism resides in the lumen of the urogenital tract. The organism releases cytotoxic proteins that destroy the epithelial lining. During an infection, the vaginal pH usually increases.   3)Gardnerella vaginalis is an anaerobic bacterium that resides in the normal vaginal flora. Normally, vaginal flora is predominated by the lactobacilli species, but when organisms such as gardnerella begin to overgrow and become the dominant species, this leads to bacterial vaginosis (BV). Bacterial vaginosis is characterized by the presence of clue cells, which are epithelial cells of the cervix that are covered with rod-shaped bacteria. According to statistics, 11% of women have BV detected during physical examination, and 36% - 60% among vaginitis patients in gynecological clinics.     To meet the needs of market, Jiangsu Medomics Medical Technology Co., Ltd. has released a new product named Candida albicans/Trichomonas vaginalis/Gardnerella vaginalis antigen Combo Test Kit (LFIA). The test kit uses a double antibody sandwich method to detect Candida albicans, Trichomonas vaginalis, and Gardnerella vaginalis by latex microsphere immunochromatography, and is suitable for women with clinical symptoms of gynecological inflammation or suspected gynecological inflammation.       The products have following advantages:           On-site screening & quick results in 15 mins Low professional and training requirement    Unaffected by medication                                Obtain pathogen antigen with high specificity   Please CONTACT us if you are interested. We will be ready to provide you with the best possible service. 
2023-03-27
Medomics

Medomics has launched Candida albicans/ Trichomonas vaginalis/ Gardnerella vaginalis antigen Combo Test Kit (LFIA)

 Reproductive tract infection is an important part of systemic infection and has become a major public health problem in the world. Recent studies have shown that reproductive tract infection is closely related to tumor occurrence, infertility, ectopic pregnancy, premature rupture of membranes and premature delivery and so on. Almost all reproductive tract infections are accompanied by changes of genital tract microenvironment.   There are several common pathogens which are easy to cause gynecologic diseases in women:   1)Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial barriers and immune defenses. Their perturbation can lead to fungal outgrowth and the development of mucosal infections such as oropharyngeal or vulvovaginal candidiasis, and patients with compromised immunity are susceptible to life-threatening systemic infections.   2)Trichomonas vaginalis is a motile organism with a size comparable to a white blood cell. It has at least 4 flagella that provide undulating motility. The organism resides in the lumen of the urogenital tract. The organism releases cytotoxic proteins that destroy the epithelial lining. During an infection, the vaginal pH usually increases.   3)Gardnerella vaginalis is an anaerobic bacterium that resides in the normal vaginal flora. Normally, vaginal flora is predominated by the lactobacilli species, but when organisms such as gardnerella begin to overgrow and become the dominant species, this leads to bacterial vaginosis (BV). Bacterial vaginosis is characterized by the presence of clue cells, which are epithelial cells of the cervix that are covered with rod-shaped bacteria. According to statistics, 11% of women have BV detected during physical examination, and 36% - 60% among vaginitis patients in gynecological clinics.     To meet the needs of market, Jiangsu Medomics Medical Technology Co., Ltd. has released a new product named Candida albicans/Trichomonas vaginalis/Gardnerella vaginalis antigen Combo Test Kit (LFIA). The test kit uses a double antibody sandwich method to detect Candida albicans, Trichomonas vaginalis, and Gardnerella vaginalis by latex microsphere immunochromatography, and is suitable for women with clinical symptoms of gynecological inflammation or suspected gynecological inflammation.       The products have following advantages:           On-site screening & quick results in 15 mins Low professional and training requirement    Unaffected by medication                                Obtain pathogen antigen with high specificity   Please CONTACT us if you are interested. We will be ready to provide you with the best possible service. 

Jiangsu Medomics Medical Technology Co.,Ltd

At the beginning of COVID-19 on early 2020, Medomics Medical quickly responded to the call of the National Health Commission, gathered research and development forces, combined with the academician team of Zhong Nanshan, developed the COVID-19 antibody detection kit in the shortest time, and cooperated with the Respiratory Research Institute (State Key Laboratory of respiratory diseases), and published the first related paper in an international journal. At present, the new coronavirus detection series products of Mecca have passed the ISO 13485 Quality System and the EU CE Certification.

maps
APALT

FOLLOW MEDOMICS

APALT

Product Center

Infectious Disease

Contact Us

Phone： (+86) 025 - 58601060

E-mail: overseas@medomics-dx.com
Address：3 / F, Building D, Phase II, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New District, Nanjing

 

Jiangsu Medomics Medical Technology Co,Ltd    Powered By www.300.cn